Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.

Plantinga L, Lim SS, Bowling CB, Drenkard C.

Lupus Sci Med. 2016 Jul 19;3(1):e000161. doi: 10.1136/lupus-2016-000161. eCollection 2016.

2.

Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Plantinga LC, Lim SS, Patzer RE, Pastan SO, Drenkard C.

BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.

3.

Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.

Ilori TO, Enofe N, Oommen A, Cobb J, Navarrete J, Adedinsewo DA, Oshikoya O, Fevrier H, Farris AB, Plantinga L, Ojo AO.

PLoS One. 2016 Jun 15;11(6):e0157485. doi: 10.1371/journal.pone.0157485. eCollection 2016.

4.

Intermittent smoking and chronic kidney disease.

Plantinga L, Gander JC.

Nephrol Dial Transplant. 2016 May 26. pii: gfw207. [Epub ahead of print] Review. No abstract available.

PMID:
27235423
5.

Pre-ESRD Care and Mortality in Incident ESRD Patients With Multiple Myeloma.

Cobb J, Plantinga L, Luthi JC, Lynch JR, Huff ED, Mohan S, McClellan WM.

Am J Clin Oncol. 2016 Feb 15. [Epub ahead of print]

PMID:
26886949
6.

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Plantinga LC, Drenkard C, Pastan SO, Lim SS.

Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.

7.

Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA.

Gillespie BW, Morgenstern H, Hedgeman E, Tilea A, Scholz N, Shearon T, Burrows NR, Shahinian VB, Yee J, Plantinga L, Powe NR, McClellan W, Robinson B, Williams DE, Saran R.

Clin Kidney J. 2015 Dec;8(6):772-80. doi: 10.1093/ckj/sfv103. Epub 2015 Nov 3.

8.

Factors affecting willingness to receive a kidney transplant among minority patients at an urban safety-net hospital: a cross-sectional survey.

Ilori TO, Enofe N, Oommen A, Odewole O, Ojo A, Plantinga L, Pastan S, Echouffo-Tcheugui JB, McClellan W.

BMC Nephrol. 2015 Nov 21;16:191. doi: 10.1186/s12882-015-0186-2.

9.

Oxidative Balance Score and Chronic Kidney Disease.

Ilori TO, Sun Ro Y, Kong SY, Gutierrez OM, Ojo AO, Judd SE, Narayan KM, Goodman M, Plantinga L, McClellan W.

Am J Nephrol. 2015;42(4):320-7. doi: 10.1159/000441623. Epub 2015 Nov 17.

PMID:
26569393
10.

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.

Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.

11.

Dialysis Facility Transplant Philosophy and Access to Kidney Transplantation in the Southeast.

Gander J, Browne T, Plantinga L, Pastan SO, Sauls L, Krisher J, Patzer RE.

Am J Nephrol. 2015;41(6):504-11. doi: 10.1159/000438463. Epub 2015 Aug 6.

12.

Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.

Patzer RE, Plantinga LC, Paul S, Gander J, Krisher J, Sauls L, Gibney EM, Mulloy L, Pastan SO.

JAMA. 2015 Aug 11;314(6):582-94. doi: 10.1001/jama.2015.8897.

13.

Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry.

Plantinga L, Lim SS, Patzer R, McClellan W, Kramer M, Klein M, Pastan S, Gordon C, Helmick C, Drenkard C.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):357-65. doi: 10.1002/acr.22685.

PMID:
26239749
14.

Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.

15.

Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM.

Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.

16.

The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation.

Patzer RE, Gander J, Sauls L, Amamoo MA, Krisher J, Mulloy LL, Gibney E, Browne T, Plantinga L, Pastan SO; Southeastern Kidney Transplant Coalition.

BMC Nephrol. 2014 Oct 28;15:171. doi: 10.1186/1471-2369-15-171.

17.

Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.

18.

Association of U.S. Dialysis facility neighborhood characteristics with facility-level kidney transplantation.

Plantinga L, Pastan S, Kramer M, McClellan A, Krisher J, Patzer RE.

Am J Nephrol. 2014;40(2):164-73. doi: 10.1159/000365596. Epub 2014 Sep 2.

19.

Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.

Patzer RE, Plantinga L, Krisher J, Pastan SO.

Am J Transplant. 2014 Jul;14(7):1562-72. doi: 10.1111/ajt.12749. Epub 2014 May 29.

20.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk